MindMaze Therapeutics Holding S.A. RLFTF
0.22 USD 0.00 (+0.00%)
At closeAug 24, 2026, 4:00 PM EDT
0.223 Day range 0.241
0.161 52-week range 4.88
- YTD
- -90.67%
- 1 year
- -91.74%
- Market cap
- 2.81M
- EPS (ttm)
- -1.70
- P/E ratio
- -0.13
- YTD return
- -90.67%
- 1-year return
- -91.74%
- Volume
- 50
- Avg volume
- 4.40K
- Open
- 0.241
- Previous close
- 0.223
- Day's range
- 0.223 – 0.241
- 52-week range
- 0.161 – 4.88
2Y -2.8950 (-94.30%)
News
Relief Therapeutics Shareholders Approve Business Combination with NeuroX 
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 
Relief Therapeutics Publishes 2025 Half-Year Report 
Relief Therapeutics Advances Publication of 2025 Half-Year Report 
Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze 
Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 
Relief Therapeutics Announces Results of Annual General Meeting 
Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda 
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
Your note
Sign in to keep a note on RLFTF — it syncs with the Stock Master app.